GlassScriptPhysician profile
Cheryl A Hickey
NPI 1225149081
$8,011.21
in general payments reported to CMS, 2019-2025
30 companies · $2,046 in 2025
The $2,046 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,298 · 2022: $1,111 · 2023: $1,621 · 2024: $1,935 · 2025: $2,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,442 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,442.19 |
| Education | $159.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $717.62 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $707.92 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $619.56 | 2021-2025 | Blu-U, Odomzo, Absorica Ld |
| Incyte Corporation | $614.13 | 2022-2025 | Opzelura, Opzelura |
| E.R. Squibb & Sons, L.L.C. | $564.97 | 2022-2024 | Sotyktu |
| Dermavant Sciences, INC. | $519.54 | 2022-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $427.36 | 2021-2025 | |
| Leo Pharma INC. | $419.54 | 2021-2025 | Adbry, Anzupgo |
| Mayne Pharma Commercial LLC | $397.92 | 2021-2025 | |
| Amgen INC. | $379.81 | 2021-2025 | Otezla |
| Genzyme Corporation | $378.14 | 2021-2025 | |
| Galderma Laboratories, L.P. | $365.57 | 2021-2024 | Aklief, Oracea, Epsolay |
| Regeneron Healthcare Solutions, INC. | $243.27 | 2021-2025 | Dupixent, Libtayo |
| Almirall LLC | $206.37 | 2021-2025 | Seysara, Klisyri |
| Arcutis Biotherapeutics, INC. | $188.26 | 2024-2025 | Zoryve |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $160.25 | 2021-2025 | Cabtreo, Arazlo, Jublia |
| Journey Medical Corporation | $159.97 | 2022-2025 | |
| Lilly USA, LLC | $156.26 | 2022-2024 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $146.87 | 2021-2022 | |
| Botanix Sb INC | $145.42 | 2025 | Sofdra |
| Organon LLC | $141.36 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $111.26 | 2021 | |
| Ucb, INC. | $90.83 | 2022-2025 | Bimzelx, Cimzia |
| Biofrontera INC. | $45.13 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Springworks Therapeutics, INC. | $27.63 | 2025 | Gomekli |
| Solta Medical, A Division of Bausch Health US, LLC | $18.19 | 2022 | |
| Janssen Scientific Affairs, LLC | $15.89 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.34 | 2025 | Nuzyra |
| Dermira, INC. | $14.24 | 2021 | |
| Angiodynamics, INC. | $13.59 | 2025 | Venacure 1470 Pro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Hickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.